Evidence map›Paper›PMID 33507371›Full record

ArticleJournal of neurology2021

Thalamic atrophy in patients with pure hereditary spastic paraplegia type 4.

Francisco J Navas-Sánchez, Alberto Fernández-Pena, Daniel Martín de Blas, Yasser Alemán-Gómez, Luís Marcos-Vidal, Juan A Guzmán-de-Villoria, Pilar Fernández-García, Julia Romero, Irene Catalina, Laura Lillo and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 3 countries.

Francisco J Navas-SánchezInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. jnavas@hggm.es.ORCID http://orcid.org/0000-0002-2954-228X
Alberto Fernández-PenaInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Daniel Martín de BlasInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Yasser Alemán-GómezDepartment of Psychiatry, Centre Hospitalier Universitaire Vaudois, Prilly, Switzerland.
Luís Marcos-VidalInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Juan A Guzmán-de-VilloriaInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Pilar Fernández-GarcíaHospital Madrid Montepríncipe, Madrid, Spain.
Julia RomeroInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Irene CatalinaServicio de Neurología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Laura LilloHospital Ruber Internacional, Servicio de Neurología, Madrid, Spain.
José L Muñoz-BlancoServicio de Neurología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Andrés Ordoñez-UgaldeLaboratorio Biomolecular, Cuenca, Ecuador.
Beatriz QuintánsInstituto de Investigación Sanitaria, Santiago de Compostela, Spain.
Julio PardoDepartamento de Neurología, Hospital Clínico Universitario de Santiago de Compostela, A Coruña, Santiago de Compostela, Spain.
María-Jesús SobridoInstituto de Investigación Sanitaria, Santiago de Compostela, Spain.
Susanna CarmonaInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Francisco Grandas *Servicio de Neurología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Manuel Desco *Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Hospital General Universitario Gregorio Marañón · ESComplejo Hospitalario Universitario de Santiago · ESCentre for Biomedical Network Research on Rare Diseases · ESHospital Universitario Fundación Alcorcón · ESHospital Universitario HM Madrid · ESSpanish National Centre for Cardiovascular Research · ESUniversity Hospital of Lausanne · CHUniversity of Cuenca · EC

Funding

Horizon 2020 Framework Programme 801091Instituto de Salud Carlos III CP16/00096Instituto de Salud Carlos III PS09/00839Instituto de Salud Carlos III PS09/01830Instituto de Salud Carlos III. Centro Nacional de Investigaciones Cardiovasculares (ES) SEV-2015-0505Instituto de Salud Carlos III (ES) PS09/01685
6 · The paper itself

Abstract

SPG4 is an autosomal dominant pure form of hereditary spastic paraplegia (HSP) caused by mutations in the SPAST gene. HSP is considered an upper motor neuron disorder characterized by progressive spasticity and weakness of the lower limbs caused by degeneration of the corticospinal tract. In other neurodegenerative motor disorders, the thalamus and basal ganglia are affected, with a considerable impact on disease progression. However, only a few works have studied these brain structures in HSP, mainly in complex forms of this disease. Our research aims to detect potential alterations in the volume and shape of the thalamus and various basal ganglia structures by comparing 12 patients with pure HSP and 18 healthy controls. We used two neuroimaging procedures: automated segmentation of the subcortical structures (thalamus, hippocampus, caudate nucleus, globus pallidus, and putamen) in native space and shape analysis of the structures. We found a significant reduction in thalamic volume bilaterally, as well as an inward deformation, mainly in the sensory-motor thalamic regions in patients with pure HSP and a mutation in SPG4. We also observed a significant negative correlation between the shape of the thalamus and clinical scores (the Spastic Paraplegia Rating Scale score and disease duration). Moreover, we found a 'Group × Age' interaction that was closely related to the severity of the disease. No differences in volume or in shape were found in the remaining subcortical structures studied. Our results suggest that changes in structure of the thalamus could be an imaging biomarker of disease progression in pHSP.

Indexed as

Spastic Paraplegia, HereditaryAtrophyBasal GangliaHumansMutationParaplegiaSpastinSpastinSPAST protein, humanAtrophyBiomarkersNeuroimagingSpastic paraplegiaThalamus

Identifiers

PMID33507371
OpenAlexW3123796701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.